Inventor · disambiguated record
Niels P. Ryde
Also filed as: RYDE NIELS · RYDE NIELS P · RYDE NIELS PETER · RYDE NIELS-PETER MOESGAARD
22 granted patents·12 pending applications·1,093 citations·filing 2000–2021
96Inventor score
Files withELAN PHARMA INT LTD19ALKERMES PHARMA IRELAND LTD8ALKERMES PHARMA IRLAND LTD1BOSCH H WILLIAM1COOPER EUGENE R1
Top patents by PatentIndex Score
34 records- 0199US6592903B2Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinateELAN PHARMA INT LTD·Filed 2002·Granted Jul 15, 2003·216 cites·33 claims
- 0299US6375986B1Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinateELAN PHARMA INT LTD·Filed 2000·Granted Apr 23, 2002·349 cites·34 claims
- 0398US6431478B1Small-scale mill and method thereofELAN PHARMA INT LTD·Filed 2000·Granted Aug 13, 2002·153 cites·36 claims
- 0496US6969529B2Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizersELAN PHARMA INT LTD·Filed 2003·Granted Nov 29, 2005·69 cites·38 claims
- 0595US7244451B2Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizersELAN PHARMA INT LTD·Filed 2005·Granted Jul 17, 2007·17 cites·22 claims
- 0694US11717481B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Aug 8, 2023·2 cites·40 claims
- 0794US7198795B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2002·Granted Apr 3, 2007·62 cites·19 claims
- 0892US7459283B2Nanoparticulate compositions having lysozyme as a surface stabilizerELAN PHARMA INT LTD·Filed 2003·Granted Dec 2, 2008·38 cites·57 claims
- 0991US9345665B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2013·Granted May 24, 2016·13 cites·14 claims
- 1091US7763278B2Nanoparticulate polycosanol formulations and novel polycosanol combinationsELAN PHARMA INT LTD·Filed 2003·Granted Jul 27, 2010·42 cites·66 claims
- 1189US6745962B2Small-scale mill and method thereofELAN PHARMA INT LTD·Filed 2001·Granted Jun 8, 2004·70 cites·75 claims
- 1288US7695739B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2007·Granted Apr 13, 2010·6 cites·18 claims
- 1385US7998507B2Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitorsELAN PHARMA INT LTD·Filed 2005·Granted Aug 16, 2011·6 cites·35 claims
- 1484US11253478B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Feb 22, 2022·1 cites·14 claims
- 1582US8309136B2In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositionsCOOPER EUGENE R·Filed 2010·Granted Nov 13, 2012·3 cites·14 claims
- 1682US6991191B2Method of using a small scale millELAN PHARMA INT LTD·Filed 2004·Granted Jan 31, 2006·40 cites·60 claims
- 1780US9974746B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted May 22, 2018·2 cites·15 claims
- 1874US9974748B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted May 22, 2018·1 cites·15 claims
- 1974US9974747B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted May 22, 2018·1 cites·15 claims
- 2073US8323641B2Nanoparticulate compositions having lysozyme as a surface stabilizerWERTZ CHRISTIAN F·Filed 2008·Granted Dec 4, 2012·1 cites·23 claims
- 2170US2008152585A1Low viscosity liquid dosage formsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2265US8236352B2Glipizide compositionsBOSCH H WILLIAM·Filed 2003·Granted Aug 7, 2012·1 cites·49 claims
- 2363US2013251805A1Low viscosity liquid dosage formsALKERMES PHARMA IRELAND LTD·Filed 2012·Application pending·0 cites
- 2461US2004105889A1Low viscosity liquid dosage formsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 2560US2014234225A1Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizerALKERMES PHARMA IRELAND LTD·Filed 2014·Application pending·0 cites
- 2655US8652464B2Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizerALKERMES PHARMA IRLAND LTD·Filed 2012·Granted Feb 18, 2014·0 cites·21 claims
- 2754US2010316725A1Reduction of flake-like aggregation in nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2010·Application pending·0 cites
- 2852US2008220074A1Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making sameELAN CORP PLC·Filed 2008·Application pending·0 cites
- 2950US2004258757A1Liquid dosage compositions of stable nanoparticulate active agentsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 3047US2008241070A1Fenofibrate dosage formsFOURNIER LAB IRELAND LTD·Filed 2008·Application pending·0 cites
- 3145US2011165251A1Liquid dosage compositions of stable nanoparticulate active agentsELAN PHARMA INT LTD·Filed 2011·Application pending·0 cites
- 3244US2004033202A1Nanoparticulate sterol formulations and novel sterol combinationsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 3343US2010143962A1Nanoparticulate polycosanol formulations & novel polycosanol combinationsELAN PHARMA INT LTD·Filed 2010·Application pending·0 cites
- 3439US2003129242A1Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizerFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →